About ENT Disorders
Companies included in ENT Disorders sector
Medical devices, diagnostics tests, and pharmaceuticals for the diagnosis and treatment of ear, nose and throat (ENT) diseasesCompanies excluded in ENT Disorders sector
Healthcare Service Providers, Digital Health Solutions (software, apps, online platforms)Market Map of ENT Disorders
Reports related to ENT Disorders
ENT Disorders - Sector Report
Edition: September, 2026 (63 Pages)ENT Disorders Investor Landscape
Edition: May, 2025 (12 Pages)ENT - Sector Investor Analysis
Edition: 2022Top Companies in ENT Disorders
Company | Description | Location | Founded | Current Stage | Private Funding Raised |
|---|---|---|---|---|---|
Electronic hearing devices and implants | Sydney (Australia) | 1981 | Public | - | |
Provider of advanced cochlear implants and hearing technology for powerful connections | Valencia (United States) | 1993 | Acquired | $128M | |
Developer and manufacturer of hearing aids | Eden Prairie (United States) | 1967 | Funding Raised | - | |
Online platform offering hearing aids and hearing solutions | Milan (Italy) | 1949 | Public | - | |
Biotechnology firm innovating localized therapies for chronic rhinosinusitis (CRS) | Watertown (United States) | 2005 | Public | $110M |
Companies founded year-on-year in the ENT Disorders sector
33 ENT Disorders startups were founded in 2019 - this is the most number of startups founded in any year in the last 10 years.
- Total Number of Companies
Year | No. of companies |
|---|---|
2026 | - |
2025 | 1 |
2024 | 1 |
2023 | 4 |
2022 | 10 |
2021 | 10 |
2020 | 30 |
2019 | 33 |
2018 | 22 |
2017 | 26 |
Companies founded across countries in the ENT Disorders sector
United States has 195 ENT Disorders startups, the most by any country, followed by United Kingdom which has 28 startups and India which has 25.
- Total Number of Companies
Country | No. of companies |
|---|---|
United States | 195 |
United Kingdom | 28 |
India | 25 |
China | 23 |
Israel | 18 |
Germany | 16 |
Denmark | 15 |
Canada | 10 |
Italy | 10 |
Australia | 9 |
Stage-wise distribution of the ENT Disorders sector
Out of the total 457 ENT Disorders companies, 212 have secured funding. Among them, 93 have reached Series A or higher, and 66 to Series B or beyond.
Company Stage | No. of companies |
|---|---|
Founded | 457 |
Funded | 212 |
Series A+ | 93 |
Series B+ | 66 |
Series C+ | 49 |
- 455+ Total Companies
- $4.95B+ Total Funding
- 210+ Funded Companies
- 5+ IPOs
- 25+ Acquisitions
- 5+ Reports
Funding Trends in the ENT Disorders sector
Total funding year-on-year in the ENT Disorders sector
The ENT Disorders sector saw a total funding of more than $3.1B in the last 10 years. The most amount of funding was in 2020 at more than $977M. There has been a total funding of $365M in 2026 till date.
- Total Funding
Year | Total Funding |
|---|---|
2026 | $365M |
2025 | $124M |
2024 | $144M |
2023 | $274M |
2022 | $138M |
2021 | $128M |
2020 | $977M |
2019 | $205M |
2018 | $428M |
2017 | $313M |
Total funding across countries in the ENT Disorders sector
In the last 10 years, ENT Disorders startups in United States have recieved the highest funding among all countries - $1.79B. Australia follows with $555M and France with $206M.
- Total Funding
Country | Total Funding |
|---|---|
United States | $1.79B |
Australia | $555M |
France | $206M |
United Kingdom | $131M |
Denmark | $49.2M |
China | $18.1M |
Israel | $15.2M |
Germany | $14.4M |
Switzerland | $8.4M |
India | $454K |
Total funding amount raised by stage in the ENT Disorders sector
Over the last 10 years, the ENT Disorders sector have seen $101M into Seed Stage funding rounds, $843M into Early Stage funding rounds and $710M go into Late Stage funding rounds.
Funding Stage | Total Funding |
|---|---|
Post IPO | $1.03B |
Early Stage | $843M |
Late Stage | $710M |
Seed Stage | $101M |
Grant | $85.3M |
Debt | $32.7M |
Recent Funding Rounds in ENT Disorders
Company | Round Raised | Amount Raised | Funding Date | Investors |
|---|---|---|---|---|
Series D | 3578 | Sep 16, 2026 | and 2 more | |
Seed | 2024 | May 21, 2026 | ||
Series B | 7856 | Apr 16, 2026 | - | |
Series B | 9513 | Apr 2026 | ||
Series B | 1720 | Feb 27, 2026 | - |
Top Investors in ENT Disorders
Investor | Location | Top Portfolio Companies |
|---|---|---|
Washington, DC (United States) | ||
Menlo Park (United States) | ||
New York City (United States) | ||
Arlington (United States) |
M&A activity in ENT Disorders
Company | Acquisition Type | Acquisition Date | Acquirers |
|---|---|---|---|
Business Acquisition | Oct 22, 2025 | ||
Business Acquisition | Jul 02, 2025 | ||
Business Acquisition | Sep 17, 2024 | - | |
Business Acquisition | Dec 13, 2023 | ||
Business Acquisition | Aug 10, 2023 |
Acquisition trends in ENT Disorders
Here are the acquisition trends in ENT Disorders:
- Total Number of Acquisitions
Year | No. of companies |
|---|---|
2026 | - |
2025 | 2 |
2024 | 1 |
2023 | 6 |
2022 | 3 |
2021 | 2 |
2020 | 1 |
2019 | 3 |
2018 | - |
2017 | 2 |
IPOs in ENT Disorders
Company | IPO Date | Exchange Symbol |
|---|---|---|
Jan 20, 2022 | Mexican Stock Exchange (BMV) | |
Nov 11, 2021 | National Association of Securities Dealers Automated Quotations (NASDAQ) | |
Feb 12, 2021 | Frankfurt Stock Exchange (FRA) | |
Feb 12, 2021 | National Association of Securities Dealers Automated Quotations (NASDAQ) | |
Jun 26, 2020 | National Association of Securities Dealers Automated Quotations (NASDAQ) |
Colleges which produce the most ENT Disorders companies
Companies founded by alumni from top colleges in the ENT Disorders sector
Most number of ENT Disorders startups have been founded by alumni from University of Pennsylvania, Massachusetts Institute of Technology and Stanford University.
College | No. of companies |
|---|---|
University of Pennsylvania | 7 |
Massachusetts Institute of Technology | 5 |
Stanford University | 4 |
Cornell University | 3 |
Tel Aviv University | 3 |
University of California (Berkeley) | 3 |
Duke University | 2 |
Harvard Business School | 2 |
Stanford Business School | 2 |
University College London | 2 |
Total funding in companies founded by alumni from top colleges in the the ENT Disorders sector
In the last 10 years, Massachusetts Institute of Technology graduates' ENT Disorders companies have raised the most funding among top colleges. Cornell University alumni are second, and University of Toronto alumni are third.
College | Total Funding |
|---|---|
Massachusetts Institute of Technology | $417M |
Cornell University | $182M |
University of Toronto | $178M |
Duke University | $167M |
University of Limerick | $135M |
University of Cambridge | $79.4M |
Columbia Business School | $61M |
Columbia University | $61M |
University of Bristol | $55.5M |
University College London | $35.8M |
